gatipotuzumab gatipotuzumab gatipotuzumab is a humanized monoclonal antibody recognizing the tumor-specific epitope of mucin-1 (ta-muc1), enabling it to differentiate between tumor muc1 and non-tumor muc1 epitopes. gatipotuzumab is being developed by glycotope gmbh and is undergoing a phase ii clinical trial for ovarian cancer. gatipotuzumabmonoclonal antibodytypewhole antibodysourcehumanized (from mouse)targettumor specific glycosylation of muc1clinical dataother namespankomab-gex, anti-ta-muc1atc codenoneidentifierscas number1264737-26-9 ychemspidernoneunii85v55zlv2z